Angina
Medicare panel's review of myocardial revascularization complete
Published in Cancer Weekly, August 17th, 2004
CardioGenesis Corp. (CGCP), a company focused on surgical products and accessories used in angina-relieving transmyocardial revascularization (TMR) and percutaneous myocardial revascularization procedures, announced the Medicare Coverage Advisory Committee (MCAC) reviewed more than 6 years of clinical evidence regarding laser myocardial revascularization as a treatment for patients suffering from severe angina pain.
The committee members' assessments of the clinical evidence will be forwarded to the Centers for Medicare & Medicaid Services (CMS), the government agency charged with making medical coverage decisions for Medicare. CMS does not have any pending national...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-08-17)
More Articles from Cancer Weekly
- Bladder Cancer
TRIO upregulated in urinary bladder tumors - Brain Cancer
Childhood brain cancer linked to deletion of a Hedgehog pathway suppressor - Prostate Cancer
Combining radiation modalities increases success - Solid Tumors
Second-generation Hsp90 inhibitor to be studied in advanced solid tumor patients - Tumor Markers
Nestin expressed in some specific cell types from human testicular tumors - Angiogenesis
Bone marrow endothelial cells studied in ongoing angiogenesis - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
